Abstract
During the last decade the nanotechnologists began research on applications of nanomaterials for medicine and therapeutics. Various nanoparticles (nanomedicines) are being used worldwide for the diagnosis and management in a number of disorders including cancer and neurodegenerative disorders. The successful non-viral gene therapy is now possible with the advancements in nanotechnology. Mostly nanoparticles are divided into two main classes: organic and inorganic nanoparticles. Diverse features of nanomedicines with surface modification help to make them biocompatible with addition of varying polymer that facilitates targeted delivery of drug and its controlled release into the cells, tissues and organs. Liposomes, quantum dots, silver and gold nanoparticles are the most common examples of nanomedicines.
Keywords: Cancer, gene therapy¸ liposomes, nanomedicines, neurodegenerative disorders, quantum dots, silver and gold nanoparticles.
Current Drug Metabolism
Title:Recent Developments in Nanomedicines for Management of Various Health Issues Via Metabolism and Physico-Chemical Properties
Volume: 16 Issue: 5
Author(s): Mahmood Rasool, Muhammad Imran Naseer, Arif Malik, Abdul Manan, Ikram Ullah, Noman Bin Abid, Myeong Ok Kim, Mahmood Husain Qazi, Mohammad Amjad Kamal and Fehmida Bibi
Affiliation:
Keywords: Cancer, gene therapy¸ liposomes, nanomedicines, neurodegenerative disorders, quantum dots, silver and gold nanoparticles.
Abstract: During the last decade the nanotechnologists began research on applications of nanomaterials for medicine and therapeutics. Various nanoparticles (nanomedicines) are being used worldwide for the diagnosis and management in a number of disorders including cancer and neurodegenerative disorders. The successful non-viral gene therapy is now possible with the advancements in nanotechnology. Mostly nanoparticles are divided into two main classes: organic and inorganic nanoparticles. Diverse features of nanomedicines with surface modification help to make them biocompatible with addition of varying polymer that facilitates targeted delivery of drug and its controlled release into the cells, tissues and organs. Liposomes, quantum dots, silver and gold nanoparticles are the most common examples of nanomedicines.
Export Options
About this article
Cite this article as:
Rasool Mahmood, Imran Naseer Muhammad, Malik Arif, Manan Abdul, Ullah Ikram, Bin Abid Noman, Ok Kim Myeong, Husain Qazi Mahmood, Amjad Kamal Mohammad and Bibi Fehmida, Recent Developments in Nanomedicines for Management of Various Health Issues Via Metabolism and Physico-Chemical Properties, Current Drug Metabolism 2015; 16 (5) . https://dx.doi.org/10.2174/1389200215666141125121211
DOI https://dx.doi.org/10.2174/1389200215666141125121211 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Tissue Distribution and Metabolism of Micro- and Nanoparticles and Medical Implants
With the continuous advancement of modern science and engineering, numerous functional materials and active molecules have been developed and utilized in various industrial, medical, and food applications. Many of these can enter the body, either actively or passively, and have significant and intricate impacts on human health. For example, biomaterials ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Rationally Designed Multi-Targeted Agents Against Neurodegenerative Diseases
Current Medicinal Chemistry Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD
Current Alzheimer Research Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases
Current Medicinal Chemistry Recent Advances in Nanoneurology for Drug Delivery to the Brain
Current Nanoscience Introduction from the Editor-In-Chief
Current Neurovascular Research Preparation of Hymenialdisine, Analogues and Their Evaluation as Kinase Inhibitors
Current Medicinal Chemistry Gene Therapy Approaches to Ataxias
Current Gene Therapy Commentary (Brilliant Blue G: What a Little More Colour Can Be)
CNS & Neurological Disorders - Drug Targets Pin1: A New Outlook in Alzheimers Disease
Current Alzheimer Research Physiopathological Roles of P2X Receptors in the Central Nervous System
Current Medicinal Chemistry Glucose Blood Levels as a Therapeutic Target in Acute Ischaemic Stroke Setting
Current Topics in Medicinal Chemistry Effect of Ionic Strength on the Aggregation Propensity of Aβ<sub>1-42</sub> Peptide: An In-silico Study
Current Chemical Biology Selective Modulator of Cannabinoid Receptor Type 2 Reduces Memory Impairment and Infarct Size During Cerebral Hypoperfusion and Vascular Dementia
Current Neurovascular Research Structure Diversity, Synthesis, and Biological Activity of Cyathane Diterpenoids in Higher Fungi
Current Medicinal Chemistry Treatment of Epileptic Encephalopathies
Current Pharmaceutical Design Two Nitrogen-containing Ligands as Inhibitors of Metal-Induced Amyloid β-Peptide Aggregation
CNS & Neurological Disorders - Drug Targets Glutamate Binding-Site Ligands of NMDA Receptors
Current Medicinal Chemistry Oxidative/Nitrosative Brain Damage in Stress: Possible Target for Neuropsychopharmacological Drugs
Current Medicinal Chemistry - Central Nervous System Agents Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases
Current Alzheimer Research